Frequency of TERT promoter mutations in human cancers

Cited by (886)

Items 601–700 of 886

1. Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia
   Sunniyat Rahman, Gianna Bloye, Nadine Farah, Jonas Demeulemeester, Joana R. Costa, David O’Connor, Rachael Pocock, Tanya Rapoz-D’Silva, Adam Turňa, Lingyi Wang et al. · 2024 · Blood
2. Alternative transcription increases isoform complexity in Long Non-Coding RNAs and alters their functions in cancer
   Max Bone, Gareth J. Inman · 2025 · Non-coding RNA Research
3. Somatic genetic alterations in the development and progression in thyroid tumors of follicular cells
   Giulia Calafato, Floriana Jessica Di Paola, Antonio De Leo, Thais Maloberti, Sara Coluccelli, Laura Poppi, Andrea Repaci, Erica Solaroli, Stefania Damiani, Stefano Chillotti et al. · 2025 · European Thyroid Journal
4. InTERTwined: How TERT promoter mutations impact BRAFV600E-driven thyroid cancers
   Iñigo Landa · 2023 · Current Opinion in Endocrine and Metabolic Research
5. Regulation of telomerase towards tumor therapy
   Siyu Yan, Lin Song, Hongxin Qiu, Xining Wang, Yijun He, Chuanle Wang, Yan Y. Huang · 2023 · Cell & Bioscience
6. Comprehensive behavioural assessment of TERT in bladder cancer
   Meryem El Azzouzi, Hajar El Ahanidi, Ilias Hassan, M. Tetou, Ahmed Ameur, Mounia Bensaid, Abderrahmane Al Bouzidi, Mohamed Oukabli, Chaimae Hafidi Alaoui, Boutaina Addoum et al. · 2024 · Urologic Oncology Seminars and Original Investigations
7. Insights in biomarkers complexity and routine clinical practice for the diagnosis of thyroid nodules and cancer
   Maria de Lurdes Matos, Mafalda Pinto, Ana Gonçalves, Şule Canberk, Maria João Bugalho, Paula Soares · 2025 · PeerJ
8. pmTOR is a marker of aggressiveness in papillary thyroid carcinomas
   Catarina Tavares, Maria João Coelho, Miguel Melo, Adriana Gaspar da Rocha, Ana Pestana, Rui Batısta, Catarina Salgado, Catarina Eloy, Luciana Bueno Ferreira, Elisabete Rios et al. · 2016 · Surgery
9. Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas
   Sofia Silva Pereira, Valdemar Máximo, Ricardo Coelho, Rui Batısta, Paula Soares, Susana G. Guerreiro, Manuel A. Sobrinho-Simões, Mariana Pereira Monteiro, Duarte Pignatelli · 2016 · Journal of Cellular Biochemistry
10. Estudio de la expresión de telomerasa en una serie de neoplasias melanocíticas
    Blanca de Unamuno Bustos, A. Sahuquillo Torralba, Paula Molés‐Poveda, Gema Pérez-Simó, J. Simarro Farinos, Margarita Llavador Ros, Sarai Palanca Suela, Rafael Botella Estrada · 2018 · Actas Dermo-Sifiliográficas
11. Cancer regulatory variation
    Rebecca C. Hennessey, Kevin M Brown · 2021 · Current Opinion in Genetics & Development
12. Direct molecular evidence for both multicentric and monoclonal carcinogenesis followed by transdifferentiation from hepatocellular carcinoma to cholangiocarcinoma in a case of metachronous liver cancer
    Sumie Ohni, Hiromi Yamaguchi, Yukari Hirotani, Yoko Nakanishi, Yutaka Midorikawa, Masahiko Sugitani, Hiromu Naruse, Tomohiro Nakayama, Makoto Makishima, Mariko Esumi · 2021 · Oncology Letters
13. Circulating Virus–Host Chimera DNAs in the Clinical Monitoring of Virus-Related Cancers
    Chiao‐Ling Li, Shiou‐Hwei Yeh, Pei‐Jer Chen · 2022 · Cancers
14. Therapeutic Targets in Telomerase and Telomere Biology of Cancers
    Rajendra Prasad, Deeksha Pal, Wajid Mohammad · 2020 · Indian Journal of Clinical Biochemistry
15. Towards functional maps of non-coding variants in cancer
    Yihan Wang, Gary C. Hon · 2024 · Frontiers in Genome Editing
16. Differential gene expression analysis supports dysregulation of mitochondrial activity as a new perspective for glioblastoma's aggressiveness
    Ricardo Cunha de Oliveira, Felipe Gouvêa de Souza, Ana Gabrielle Bispo, Matheus Caetano Epifane-de-Assunção, Giovanna C. Cavalcante · 2024 · Heliyon
17. Circulating tumor DNA monitoring detects minimal residual disease and predicts outcomes in patients with esophageal adenocarcinoma or squamous cell carcinoma after esophagectomy
    Qingjiang Hu, Yasue Kimura, Shinichiro Ikeda, Yasushi Tanaka, Tomonori Nakanoko, Mitsuhiko Ota, Tomoharu Yoshizumi, Masatoshi Eto, Eiji Oki · 2025 · BJC Reports
18. Evolutionarily conserved role of telomerase reverse transcriptase in programming the microenvironment via regulation of the cGAS–STING pathway
    Semih Can Akıncılar, Kerem Fidan, Naveen Kumar, Qin Feng Ng, Prativa Majee, Lele Wu, Darryl JY Han, Claire Hian Tzer Chan, Joelle Y.H. Chua, Khaireen Idzham et al. · 2025 · Nature Cell Biology
19. The Interplay of Aging and Cancer: Mechanisms, Implications, and Therapeutic Strategies
    Liangce Wang, Yaru Luo, Xin Chen, Yuan Wang, Yan Zhang · 2025 · MedComm – Oncology
20. A Targeted Next-Generation Sequencing Panel to Genotype Gliomas
    Maria Guarnaccia, Laura Guarnaccia, Valentina La Cognata, Stefania Elena Navone, Rolando Campanella, Antonella Maria Ampollini, Marco Locatelli, Monica Rosa Miozzo, Giovanni Marfia, Sebastiano Cavallaro · 2022 · Life
21. Histopathology of telomerase reverse transcriptase promoter (TERT) mutated indeterminate thyroid nodules
    Jessica O. Pinto, Masha Jean Livhits, Michael W. Yeh, Atanas Kaykov, Joshua Paul Klopper, Richard T. Kloos, Mohammed Alshalalfa, Yangyang Hao, Jing Huang, Mayumi Endo · 2023 · Journal of Clinical & Translational Endocrinology
22. Is serum‐derived exosomal hTERT transcript a marker of oncogenic activity in primary brain tumors? An exploratory study
    Orit Uziel, Andrew A. Kanner, Einat Beery, Sapir Lev, Meir Lahav, Suzana Horn‐Fichman, Sagi Har Nof, Yuseph Laviv, Shlomit Yust‐Katz, Alexandra Benouaich‐Amiel et al. · 2023 · Cancer Medicine
23. From infection to immortality: The role of HPV and telomerase in head and neck cancer
    Silvia Giunco, Annarosa Del Mistro, Marzia Morello, Jacopo Lidonnici, Helena Frayle, Silvia Gori, Anita De Rossi, Paolo Boscolo‐Rizzo · 2025 · Oral Oncology
24. Exploring the role of TERT in thyroid Cancer: A systematic review
    Thais Maloberti, Andrea Repaci, Laura Poppi, Floriana Jessica Di Paola, Giulia Calafato, Sara Coluccelli, Francesca Carosi, Alessandra Colapinto, Simone Colombero, Giacomo Credi et al. · 2025 · Critical Reviews in Oncology/Hematology
25. Characterization of tree shrew telomeres and telomerase
    Jian Sun, Wenjing Liu, Yongbo Guo, Hailin Zhang, Dewei Jiang, Ying Luo, Rong Liu, Ceshi Chen · 2021 · Journal of genetics and genomics/Journal of Genetics and Genomics
26. The TERT Promoter: A Key Player in the Fight for Cancer Cell Immortality
    Tsimur N. Hasanau, Eduard Pisarev, Кисиль Ольга Валерьевна, Maria I. Zvereva · 2023 · Biochemistry (Moscow)
27. Development of software and modification of Q-FISH protocol for estimation of individual telomere length in immunopathology
    M. Sh. Barkovskaya, Anton G. Bogomolov, Nadezhda Knauer, Н. Б. Рубцов, Kozlov Va · 2016 · Journal of Bioinformatics and Computational Biology
28. Molecular characterization of short-term primary cultures and comparison with corresponding tumor tissue of Brazilian glioblastoma patients
    Adriana Cruvinel‐Carloni, Renato José da Silva Oliveira, Raul Torrieri, Lucas Tadeu Bidinotto, Gustavo Nóriz Berardinelli, Viviane Aline Oliveira-Silva, Carlos Clara, Gisele Caravina de Almeida, Olga Martinho, Jeremy Andrew Squire et al. · 2017 · Translational Cancer Research
29. Pathologies of matrix metalloproteinase-2 underactivity: a perspective on a neglected condition
    Ryan Cook, Hassan Sarker, Carlos Fernández-Patrón · 2018 · Canadian Journal of Physiology and Pharmacology
30. TERTmonitor Efficacy and Performance in Detecting Mutations by Droplet Digital PCR
    Mafalda Bessa‐Gonçalves, João Paulo Brás, Tito T. Jesus, Hugo Prazeres, Paula Soares, João Vinagre · 2024 · Genes
31. The nuclear condensates of ESE3/EHF induce cellular senescence without the associated inflammatory secretory phenotype in pancreatic ductal adenocarcinoma
    Tianxing Zhou, Jingrui Yan, Bohang Xu, Yu Zhang, Guohua Mao, Yongjie Xie, Qingxiao Fang, Bin Wang, Ziyun Liu, Yiping Zou et al. · 2024 · Cancer Letters
32. Rare genetic associations with human lifespan in UK Biobank are enriched for oncogenic genes
    Jun Young Park, Andrés Peña‐Tauber, Lia Talozzi, Michael D. Greicius, Yann Le Guen · 2025 · Nature Communications
33. NONO, SFPQ, and PSPC1 promote telomerase recruitment to the telomere
    Alexander P. Sobinoff, Jadon Wells, Maurice Chow, Christopher B. Nelson, Xinyi Wu, Scott B. Cohen, Yu Heng Lau, Tracy M. Bryan, Archa H. Fox, Hilda A. Pickett · 2025 · Nature Communications
34. Telomere length and Wnt/β-catenin pathway in adamantinomatous craniopharyngiomas
    José Ítalo Soares Mota, Rui Milton Patrício da Silva-Júnior, Clarissa Silva Martins, Ana Carolina Bueno, Luiz Eduardo Wildemberg, Ximene Lima da Silva Antunes, Jorge Guilherme Okanobo Ozaki, Fernanda Borchers Coeli‐Lacchini, Carlos García-Peral, Antônio Edson Rocha Oliveira et al. · 2022 · European Journal of Endocrinology
35. Association of TERT promoter mutation with oral squamous cell carcinoma: a systematic review and meta-analysis
    Monal Bhaurao Yuwanati, Sachin Chakradhar Sarode, Gargi Sachin Sarode, Amol Ramchandra Gadbail, Shailesh Madhukar Gondivkar, Akhilanand Chaurasia, Dhara Dwivedi, Sara Delgadillo Barrera · 2025 · Scientific Reports
36. A novel truncated form of HMGA2 in tumors of the ovaries
    Antonio Agostini, Ioannis Panagopoulos, Ben Davidson, Claes Goran Trope, Sverre Heim, Francesca Micci · 2016 · Oncology Letters
37. Bibliometric insights in advances of papillary thyroid microcarcinoma: Research situation, hot points, and global trends
    Kefan Chen, Zhongqing Wang, Wei Sun, Dalin Zhang, Ting Zhang, Liang He, Hao Zhang · 2022 · Frontiers in Endocrinology
38. Thyroid carcinoma metastases to central nervous system and vertebrae
    Bette Kay Kleinschmidt-DeMasters, Carrie Marshall · 2022 · Folia Neuropathologica
39. Telomerase reverse transcriptase promoter mutation and histologic grade in IDH wild-type histological lower-grade gliomas: The value of perfusion-weighted image, diffusion-weighted image, and 18F-FDG-PET
    Satoshi Ikeda, Akihiko Sakata, Yasutaka Fushimi, Sachi Okuchi, Yoshiki Arakawa, Yasuhide Makino, Yohei Mineharu, Satoshi Nakajima, Takuya Hinoda, Kazumichi Yoshida et al. · 2022 · European Journal of Radiology
40. Absence of TERT promoter mutations in esophageal adenocarcinoma
    Anna M.J. van Nistelrooij, Ellen C. Zwarthoff, E. Post, Irene Lurkin, Ronald van Marion, E. Kopershoek, Katharina Biermann, Bas P. L. Wijnhoven, Winand N.M. Dinjens · 2013 · International Journal of Cancer
41. TERT promoter mutations are a rare event in gastrointestinal stromal tumors
    Keisuke Akaike, Midori Ishii, Yoshiyuki Suehara, Kenta Mukaihara, Daisuke Kubota, Keiko Mitani, Tatsuya Takagi, Kazuo Kaneko, Takashi Yao, Tsuyoshi Saito · 2015 · SpringerPlus
42. Expression of telomerase reverse transcriptase in peripheral T‐cell lymphoma
    Fumiko Arakawa, Hiroaki Miyoshi, Noriaki Yoshida, Kazutaka Nakashima, Yosaku Watatani, Takuya Furuta, Kyohei Yamada, Mayuko Moritsubo, Mai Takeuchi, Eriko Yanagida et al. · 2021 · Cancer Medicine
43. The Utility of Molecular Markers in Pre-Operative Assessment of Thyroid Nodules
    Parisha Bhatia, Zakaria Y. Abd Elmageed, Paul L. Friedlander, Rizwan Aslam, Emad H. Kandil · 2015 · Future Oncology
44. Absence of TERT promoter mutations in colorectal precursor lesions and cancer
    Adriana Cruvinel‐Carloni, Letícia Yamane, Cristovam Scapulatempo‐Neto, Denise Peixoto Guimarães, Rui Manuel Reis · 2018 · Genetics and Molecular Biology
45. Review of Genomic Drivers of Thyroid Cancer and Their Clinical Implications
    Sheriff Mohammed, Daniel J. Mettman, Axel Hugo Breier, Vaishali Patel, Mariana Garcia‐Touza · 2025 · Genes
46. The causal relationship between genetically determined telomere length and meningiomas risk
    Weijie Yu, Yunyun Mei, Zhenwei Lu, Liwei Zhou, Fang Jia, Sifang Chen, Zhanxiang Wang · 2023 · Frontiers in Neurology
47. Copy-number-gain of telomerase reverse transcriptase (hTERT) is associated with an unfavorable prognosis in esophageal adenocarcinoma
    Su Ir Lyu, Felix Popp, Adrian Georg Simon, Anne Maria Schultheis, Thomas Zander, Caroline Fretter, Wolfgang Schröder, Christiane J. Bruns, Thomas Schmidt, Alexander Quaas et al. · 2023 · Scientific Reports
48. TERT Promoter Mutations Increase Tumor Aggressiveness by Altering TERT mRNA Splicing in Papillary Thyroid Carcinoma
    Ayaka Sako, Michiko Matsuse, Vladimir Saenko, Aya Tanaka, Ryota Otsubo, Michi Morita, Sayaka Kuba, Eijun Nishihara, Keiji Suzuki, Tomoo Ogi et al. · 2024 · The Journal of Clinical Endocrinology & Metabolism
49. Polygenic Risk Score Improves Melanoma Risk Assessment in a Patient Cohort from the Veneto Region of Italy
    Stefania Pellegrini, Thomas P. Potjer, Paola Del Bianco, Antonella Vecchiato, Alessio Fabozzi, Luisa Piccin, Debora Tonello, Nienke van der Stoep, Emily A. Tinsley, Maria Teresa Landi et al. · 2024 · Biology
50. Molecular perspectives in differentiated thyroid cancer
    Camille Buffet, Lionel Groussin · 2015 · Annales d Endocrinologie
51. Scarcity of Recurrent Regulatory Driver Mutations in Colorectal Cancer Revealed by Targeted Deep Sequencing
    Rebecca C. Poulos, D. S. Perera, Deborah Packham, Anushi Shah, Caroline Janitz, John E. Pimanda, Nicholas John Hawkins, Robyn Lynne Ward, Luke B. Hesson, Jason W.H. Wong · 2019 · JNCI Cancer Spectrum
52. The Multifaceted Profile of Thyroid Disease in the Background of DICER1 Germline and Somatic Mutations: Then, Now and Future Perspectives
    Şule Canberk, Marcelo Correia, Ana Rita Lima, Massimo Bongiovanni, Manuel A. Sobrinho-Simões, Paula Soares, Valdemar Máximo · 2022 · Journal of Molecular Pathology
53. The Integrated Histopathologic and Molecular Approach to Adult-type Diffuse Astrocytomas: Status of the Art, Based on the 2021 WHO Classification of Central Nervous System Tumors
    Hiba Alzoubi, Alameen Alsabbah, Rosario Caltabiano, Giuseppe Broggi · 2022 · ONCOLOGIE
54. New Insights into Melanoma Tumor Syndromes
    Sarem Rashid, Sameer Gupta, Shelley R. McCormick, Hensin Tsao · 2022 · JID Innovations
55. Telomerase inhibition decreases esophageal squamous carcinoma cell migration and invasion
    Jiayan Li, Guogang Dong, Jinyun Song, Guolei Tan, Xuping Wu · 2020 · Oncology Letters
56. TERT-Promoter Mutational Status in Glioblastoma – Is There an Association With Amino Acid Uptake on Dynamic 18F-FET PET?
    Marcus Unterrainer, Viktoria Ruf, Katharina von Rohr, Bogdana Suchorska, Lena M. Mittlmeier, Leonie Beyer, Matthias Brendel, Vera Wenter, Wolfgang Gerhard Kunz, Peter Bartenstein et al. · 2021 · Frontiers in Oncology
57. Forecasting Molecular Features in IDH-Wildtype Gliomas: The State of the Art of Radiomics Applied to Neurosurgery
    Rosa Maria Gerardi, Roberto Cannella, Lapo Bonosi, Federica Vernuccio, Gianluca Ferini, Anna Viola, Valentina Zagardo, Felice Buscemi, Roberta Costanzo, Massimiliano Porzio et al. · 2023 · Cancers
58. Association between hTERT Polymorphisms and Female Papillary Thyroid Carcinoma
    Ying Liu, Zhi Li, Xinyue Tang, Min Li, Feng Shi · 2019 · Recent Patents on Anti-Cancer Drug Discovery
59. Direct comparison of the next-generation sequencing and iTERT PCR methods for the diagnosis of TERT hotspot mutations in advanced solid cancers
    So Young Kang, Deok Geun Kim, Hyunjin Kim, Yoon Ah Cho, Sang Yun Ha, Ghee Young Kwon, Kee‐Taek Jang, Kyoung‐Mee Kim · 2022 · BMC Medical Genomics
60. Potentiating immunotherapy in “immune-cold” solid tumors through orchestrating T cell immunity via tumor-specific genetic engineering
    Jiaqi He, Chunguang Zhang, Chao Liang, Wenchi Xue, Yongheng Li, Lili Dai, Chunyuan Liu, Wan‐Ru Zhuang, Xianbin Ma, Ran Cheng et al. · 2025 · Cell Reports Medicine
61. Telomerase reverse transcriptase immunohistochemical expression is sensitive but not specific for TERT gene amplification in acral melanoma
    Woo Cheal Cho, Wen Li, Jun Gu, Wei‐Lien Wang, Jing Ning, Steven M. Sfamenos, Pavandeep Gill, Priyadharsini Nagarajan, Jonathan L. Curry, Alexander J. Lazar et al. · 2023 · Journal of Cutaneous Pathology
62. Ovarian Adult Granulosa Cell Tumors: A Scoping Review of DNA Alterations and Their Known Significance
    Sven Hoedt Karstensen, KARSTEN KAISER, Tim Svenstrup Poulsen, Kirsten Marie Jochumsen, Claus Kim Høgdall, Niels Marcussen, Finn Friis Lauszus, Estrid Vilma Solyom Høgdall · 2024 · Anticancer Research
63. Disease-Specific and Histological Outcomes of Preoperative TERT Promoter Mutation Detected in Isolation or in Combination with Other Mutations in Thyroid Neoplasms
    Michael J. Calcaterra, Alaa Sada, Esra Karslioglu French, Elena M. Morariu, Kelly L. McCoy, Kimberly M. Ramonell, Saba Kurtom, N. Paul Ohori, Simion I. Chiosea, Raja R. Seethala et al. · 2025 · Thyroid
64. Design, Synthesis, Theoretical, Molecular Networking, In Silico and In Vitro Evaluation of Dehydrozingerone‐Based Mannich Derivatives as Promising Anticancer Agents
    Senthil Kumar Raju, Praveen Sekar, Badriyah Shadid Alotaibi, Murugesan Sankarganesh, Ajmal Rashid Bhat, Aso Hameed Hasan, Sumeer Ahmed, Mohammad Amjad Kamal · 2025 · ChemistrySelect
65. Telomerase reverse transcriptase (TERT) promoter mutations in the tumors of human endocrine organs: Biological and prognostic value
    Л С Селиванова, K S Volganova, Abrosimov AIu · 2016 · Russian Journal of Archive of Pathology
66. Das Urachuskarzinom – aktuelle Konzepte einer seltenen Tumorerkrankung
    Henning Reis, Tibor Szarvas · 2018 · Der Pathologe
67. NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis
    Jing Zhang, Jason J. Liu, Patrick D. McGillivray, Caroline Yi, Lucas Lochovsky, Donghoon Lee, Mark Gerstein · 2020 · BMC Bioinformatics
68. Telomerase reverse transcriptase promoter mutation and its clinical implication in thyroid cancer
    Jae Hoon Chung · 2018 · Precision and Future Medicine
69. Case Report: Genetic Alterations Associated with the Progression of Carotid Paraganglioma
    Vladislav Pavlov, Anastasiya V. Snezhkina, Dmitry Valerievich Kalinin, Alexander Leonidovich Golovyuk, Anastasiya A. Kobelyatskaya, Ildar R. Bakhtogarimov, Н. Н. Волченко, George Sergeevich Krasnov, Anna V. Kudryavtseva · 2021 · Current Issues in Molecular Biology
70. Suppressor‐type TERT mutations associated with recurrence in ovarian clear cell carcinoma
    Tatsuya Kobayashi, Kyoko Nishikimi, Akira Mitsuhashi, Hongying Piao, Ayumu Matsuoka, Satoyo Otsuka, Shinichi Tate, Makio Shozu, Hirokazu Usui · 2023 · Genes Chromosomes and Cancer
71. Intrinsic Molecular Processes: Impact on Mutagenesis
    Byungho Lim, Jihyeob Mun, Seon‐Young Kim · 2017 · Trends in cancer
72. Modelling TERT regulation across 19 different cancer types based on the MIPRIP 2.0 gene regulatory network approach
    Alexandra Maria Poos, Theresa Kordaß, Amol Kolte, Volker Ast, Marcus Oswald, Karsten Rippe, Rainer König · 2019 · BMC Bioinformatics
73. Characteristics of the isocitrate dehydrogenase gene and telomerase reverse transcriptase promoter mutations in gliomas in Chinese patients
    Chongxiao Qu, Hongming Ji, Xiang‐Cheng Shi, Hong Sheng Bi, Liqin Zhai, De‐Wu Han · 2020 · Brain and Behavior
74. Hot Spot TERT Promoter Mutations Are Rare in Sporadic Pancreatic Neuroendocrine Neoplasms and Associated with Telomere Length and Epigenetic Expression Patterns
    Alexandra Posch, Sarah Hofer-Zeni, Eckhard Klieser, Florian Primavesi, Elisabeth Naderlinger, Anita Brandstetter, Martin Filipits, Romana Urbas, Stefan Swiercynski, Tarkan Jäger et al. · 2020 · Cancers
75. Malignant melanotic nerve sheath tumor in pleural effusion: Deceitful cytology with significant repercussions
    Christopher R. Jackson, Konstantinos D. Linos, Xiaoying Liu · 2021 · Diagnostic Cytopathology
76. E4F1 and ZNF148 are transcriptional activators of the −57A > C and wild-type TERT promoter
    Boon Haow Chua, Nurkaiyisah Zaal Anuar, Laure Ferry, Cécilia Domrane, Anna Wittek, Vineeth Thachappilly Mukundan, Sudhakar Jha, Falk Butter, Daniel Geoffrey Tenen, Pierre‐Antoine Defossez et al. · 2023 · Genome Research
77. Pan-cancer experimental characteristic of human transcriptional patterns connected with telomerase reverse transcriptase (TERT) gene expression status
    Aleksey Yu. Drobyshev, Alexander Modestov, Maria Suntsova, Elena V Poddubskaya, Alexander P. Seryakov, Aleksey Moisseev, Maxim Sorokin, Victor Tkachev, Г. С. Захарова, Aleksander Simonov et al. · 2024 · Frontiers in Genetics
78. TERT promoter mutations and additional molecular alterations in thyroid fine-needle aspiration specimens: A multi-institutional study with histopathologic follow-up
    Rita F. Abi-Raad, Qiuying Shi, Fei Chen, Vijay Antony, Wen‐Yu Hsiao, Aylin Simsir, Xiaoying Liu, Tamar C. Brandler, Guoping Cai · 2024 · American Journal of Clinical Pathology
79. Illuminating the Noncoding Genome in Cancer Using Artificial Intelligence
    María del Mar Álvarez‐Torres, Xi Fu, Raúl Rabadán · 2025 · Cancer Research
80. The Diagnostic Performance of a Four-Gene Digital Droplet PCR Panel for Urine Liquid Biopsy in Urothelial Bladder Cancer
    Mark Jain, Alexander S. Tivtikyan, Dmitry Kislyakov, Рахматуллин Тагир Ирекович, David M. Kamalov, Vladislav Kokarev, Lolita Vorobeva, Larisa Mikhailovna Samokhodskaya, M. E. Zvereva, Armais Kamalov · 2025 · Diagnostics
81. Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma
    Jung Heo, Sungjoo Lee, Jun Tae Park, Heera Yang, Hyunju Park, Chang‐Seok Ki, Young Lyun Oh, Hye In Kim, Sun Wook Kim, Jae Hoon Chung et al. · 2023 · PLoS ONE
82. Taking the brakes off telomerase
    Kamila Naxerova, Stephen Joseph Elledge · 2015 · eLife
83. Global inference of disease-causing single nucleotide variants from exome sequencing data
    Mengmeng Wu, Ting Chen, Rui Jiang · 2016 · BMC Bioinformatics
84. Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735, an Aurora Kinase Inhibitor
    Sevim Dalva-Aydemir, Cemaliye Boylu Akyerli, Şirin Yüksel, Hilal Keskin Karakoyun, Mustafa Cengiz Yakicier · 2019 · OMICS A Journal of Integrative Biology
85. Significance of telomerase reverse-transcriptase promoter mutations in differentiated thyroid cancer
    Hung-Fei Lai, Chi‐Yu Kuo, Shih‐Ping Cheng · 2021 · Formosan Journal of Surgery
86. Telomere Maintenance and Genome Stability
    Wilnelly M. Hernandez-Sanchez, Mengyuan Xu, Derek J. Taylor · 2016 · Elsevier eBooks
87. SMuRF: a novel tool to identify regulatory elements enriched for somatic point mutations
    Paul Guilhamon, Mathieu Lupien · 2018 · BMC Bioinformatics
88. Expression of the Reverse Transcriptase Domain of Telomerase Reverse Transcriptase Induces Lytic Cellular Response in DNA-Immunized Mice and Limits Tumorigenic and Metastatic Potential of Murine Adenocarcinoma 4T1 Cells
    Juris Jansons, Баюрова Екатерина Олеговна, Dace Skrastiņa, Alisa Kurlanda, Ilze Fridrihsone, Dmitry S. Kostyushev, Anastasiya Kostyusheva, Alexander Artyuhov, Erdem Bairovich Dashinimaev, Darya Avdoshina et al. · 2020 · Vaccines
89. Telomere length as a biomarker of aging and diseases
    Azra Guzonjić, Miron Sopić, Barbara Ostanek, Jelena Kotur‐Stevuljević · 2022 · Arhiv za farmaciju
90. TERT genetic polymorphism rs2736100 is associated with an aggressive manifestation of papillary thyroid carcinoma
    Xilin Nie, Jinbiao Shang, Wendong Wang · 2023 · Frontiers in Surgery
91. Spotlight on hTERT Complex Regulation in Cutaneous T-Cell Lymphomas
    Joana Ropio, Martina Prochazkova‐Carlotti, Rui Batısta, Ana Pestana, Alain Chebly, Jacky Ferrer, Yamina Idrissi, David Cappellen, Cecília Durães, Paula Boaventura et al. · 2023 · Genes
92. Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer
    Tsung‐Jang Yeh, Chi‐Wen Luo, Jeng‐Shiun Du, Chien-Tzu Huang, Min-Hung Wang, Benjamin Tzer-Ming Chuang, Yuh‐Ching Gau, Shih‐Feng Cho, Yi‐Chang Liu, Hui‐Hua Hsiao et al. · 2023 · Biomedicines
93. Conserved G-Quadruplex-Forming Sequences in Mammalian TERT Promoters and Their Effect on Mutation Frequency
    Vera V. Panova, Nina G. Dolinnaya, Kirill A. Novoselov, Viktoriia Yu. Savitskaya, Ivan S. Chernykh, Elena Aleksandrovna Kubareva, Andrei V. Alexeevski, Maria I. Zvereva · 2023 · Life
94. Cis -regulatory Element Hijacking by Structural Variants Overshadows Higher-Order Topological Changes in Prostate Cancer
    James R. Hawley, Stanley Zhou, Christopher Arlidge, Giacomo Grillo, Ken Kron, Rupert Hugh-White, Theodorus van der Kwast, Michael E. Fraser, Paul C. Boutros, Robert Glen Bristow et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
95. Somatic Mutations and Risk-Variants Converge on Cis-Regulatory Elements to Reveal the Cancer Driver Transcription Regulators in Primary Prostate Tumors
    Parisa Mazrooei, Ken J. Kron, Yanyun Zhu, Tahmid Mehdi, Stanley Zhou, Musaddeque Ahmed, Tesa Severson, Paul Guilhamon, Nicholas Sinnott Armstrong, Vincent Huang et al. · 2018 · SSRN Electronic Journal
96. Non-Invasive Urine-Based Diagnostic Technologies for Early Bladder Cancer
    Zhe Hao, Shuhua Yue, Yanqing Gong, Jian Yu, Lin Yao, Liqun Zhou · 2026 · Biosensors
97. TERT Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy
    Francisco Martins, César Martins, Margarida Sá Fernandes, Maria Isabel Andrade, José Manuel Lopes, Paula Soares, Helena Pópulo · 2021 · Dermatology
98. The utility of next‐generation sequencing in challenging liver FNA biopsies
    Dana J. Balitzer, Nancy Greenland · 2024 · Cancer Cytopathology
99. Cancer somatic mutations cluster in a subset of regulatory sites predicted from the ENCODE data
    Nisar Ahmed Shar, M. S. Vijayabaskar, David R. Westhead · 2016 · Molecular Cancer
100. Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes
     Nadin D. Exner, Jaime Alberto Campos Valenzuela, Khalil Abou‐El‐Ardat, Hrvoje Miletić, Peter Csaba Huszthy, Petra M. Radehaus, Evelin Schröck, Rolf Bjerkvig, Lars Kaderali, Barbara Klink et al. · 2019 · Oncotarget